Lumexa Imaging Cash Flow Statement
NASDAQ: LMRIHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Lumexa Imaging has no annual cash flow statement on file yet, so quarterly figures are shown instead.
Lumexa Imaging free cash flow
In the quarter ended Jun 30, 2026, Lumexa Imaging generated $32.8 million of operating cash flow and spent $9.7 million on capital expenditures. That left free cash flow of $23.1 million, a free-cash-flow margin of 8.8% of revenue.
Summary generated from market data by MetaCap's automated system. Methodology
Lumexa Imaging cash flow statement (quarterly)
| Quarter (USD) | Q2 20262026-06-30 | Q1 20262026-03-31 | Q? 20252025-06-30 | Q? 20252025-03-31 |
|---|---|---|---|---|
| Net Income | 2.75M | 1.72M | -7.23M | -7.69M |
| Net Income growth (YoY) | — | — | — | — |
| Depreciation & Amortization | 10.08M | 9.92M | 9.28M | 9.05M |
| Stock-Based Compensation | 12.74M | 12.27M | 8.35M | 6.37M |
| Change in Working Capital | -14.62M | -12.60M | -2.44M | -7.51M |
| Operating Cash Flow | 32.80M | 2.93M | 2.07M | -13.96M |
| Capital Expenditures | -9.67M | -5.31M | -4.60M | -1.00M |
| Investing Cash Flow | -13.64M | -5.27M | -4.17M | -720.00K |
| Debt Issued | 8.41M | 1.12M | 0 | 496.00K |
| Debt Repaid | -5.17M | -3.23M | -3.93M | -3.89M |
| Financing Cash Flow | -685.00K | -5.26M | -462.00K | -4.15M |
| Net Change in Cash | 18.48M | -7.60M | -2.56M | -18.83M |
| Free Cash Flow | 23.13M | -2.38M | -2.53M | -14.96M |
This table shows 4 quarterly periods of Lumexa Imaging's cash flow statement, from Q2 2026 back to Q? 2025, across 12 line items including net income, depreciation & amortization, stock-based compensation. Values in USD; B = billions, M = millions. Fiscal periods follow LMRI's reporting calendar. What is a cash flow statement?